Interestingly, previous immunohistochemical studies reported that the level of uPAR in primary pancreatic adenocarcinoma was higher than in normal pancreas and tended to be associated with a worse prognosis [32-34]. This evidence concerns the gene PLAUR and pancreatic adenocarcinoma.